These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15080308)

  • 21. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
    Lane Z; Epstein JI; Ayub S; Netto GJ
    Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
    Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
    Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
    Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
    Zhang W; Hart J; McLeod HL; Wang HL
    Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of beta-catenin in esophageal carcinoma].
    Zhou XB; Lu N; Zhang W; Quan LP; Lin DM; Wang QH; Li YL; Xu NZ
    Ai Zheng; 2002 Aug; 21(8):877-80. PubMed ID: 12478897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.
    Koga Y; Yao T; Hirahashi M; Kumashiro Y; Ohji Y; Yamada T; Tanaka M; Tsuneyoshi M
    Histopathology; 2008 Apr; 52(5):569-77. PubMed ID: 18370954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
    Goldstein NS
    Am J Clin Pathol; 2002 Mar; 117(3):471-7. PubMed ID: 11888088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
    Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas].
    Xiao Y; Chen J; Luo YF; Cao JL; Ling Q; Jin F
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1362-6. PubMed ID: 15387946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction.
    Wijnhoven BP; Tucker ET; Dinjens WN; Tilanus HW; Pignatelli M
    Anticancer Res; 2004; 24(3a):1369-75. PubMed ID: 15274297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma.
    Suzuki H; Masuda N; Shimura T; Araki K; Kobayashi T; Tsutsumi S; Asao T; Kuwano H
    Anticancer Res; 2008; 28(3B):1821-30. PubMed ID: 18630466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.